RIGHT REMEDIES Mucus Relief DM
NDC 70692-181, Dextromethorphan Hydrobromide, Guaifenesin, tablet, from Strive Pharmaceuticals Inc..
- Product NDC
- 70692-181
- Status
- Listed
- Labeler
- Strive Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70692-181 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE20 mg/1
- GUAIFENESIN400 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70692-181-25 | 70692018125 | 250 TABLET in 1 BOTTLE (70692-181-25) |
| 70692-181-81 | 70692018181 | 180 TABLET in 1 BOTTLE (70692-181-81) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70692-181 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70692-181 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70692-181. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.